Literature DB >> 18779652

Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.

Young Won Yoon1, Tae Soo Kang, Byoung Kwon Lee, Woochul Chang, Ki-Chul Hwang, Ji-Hyuck Rhee, Pil-Ki Min, Bum-Kee Hong, Se-Joong Rim, Hyuck Moon Kwon.   

Abstract

Advanced glycation endproducts (AGEs) have been reported to play a role in neointimal formation and increase the rate of in-stent restenosis (ISR) in the diabetic coronary artery disease patients treated with stents, but the potential pathogenic mechanisms of AGEs in vascular smooth muscle cell proliferation remain unclear. We sought to determine the AGEs related pathobiological mechanism of diabetic vasculopathy. Rat aortic smooth muscle cell (RAoSMC) culture was done with different concentrations of AGEs and proliferation was assessed. Immunohistochemistry for receptor of AGEs (RAGE) was performed with human carotid atheroma. Western blotting was performed to assess the activation of MAP kinase system in the cultured RAoSMC. AGEs increased RAoSMC proliferation and were associated with increased phosphorylation of ERK and p38 kinase by time and dose dependent manner. The MAP kinase activity was decreased by RNA interference for RAGE. AGEs stimulation increased reactive oxygen species (ROS) generation in cultured RAoSMC. From this study it is concluded that AGEs played a key role in RAoSMC proliferation via MAP kinase dependent pathways. Activation of vascular smooth muscle cell (VSMC) proliferation by MAP kinase system and increased formation of ROS may be the possible mechanisms of AGEs induced diabetic vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779652      PMCID: PMC2679265          DOI: 10.3858/emm.2008.40.4.398

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  31 in total

1.  Inhibition of MEK1,2/ERK mitogenic pathway by estrogen with antiproliferative properties in rat aortic smooth muscle cells.

Authors:  Ki Chul Hwang; Kyung Hye Lee; Yangsoo Jang
Journal:  J Steroid Biochem Mol Biol       Date:  2002-01       Impact factor: 4.292

2.  Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.

Authors:  E Van Belle; C Bauters; E Hubert; J C Bodart; K Abolmaali; T Meurice; E P McFadden; J M Lablanche; M E Bertrand
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

3.  Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes.

Authors:  Shi-Yan Li; Valerie K Sigmon; Sara A Babcock; Jun Ren
Journal:  Life Sci       Date:  2006-11-25       Impact factor: 5.037

4.  Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Authors:  Taichi Sakaguchi; Shi Fang Yan; Shi Du Yan; Dmitri Belov; Ling Ling Rong; Monica Sousa; Martin Andrassy; Steven P Marso; Stephan Duda; Bernd Arnold; Birgit Liliensiek; Peter P Nawroth; David M Stern; Ann Marie Schmidt; Yoshifumi Naka
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

5.  Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats.

Authors:  C Indolfi; D Torella; L Cavuto; A M Davalli; C Coppola; G Esposito; M V Carriero; A Rapacciuolo; E Di Lorenzo; E Stabile; C Perrino; A Chieffo; F Pardo; M Chiariello
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

6.  betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin.

Authors:  Byung Heon Lee; Jong Sup Bae; Rang Woon Park; Jung Eun Kim; Jae Yong Park; In San Kim
Journal:  Exp Mol Med       Date:  2006-04-30       Impact factor: 8.718

7.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

8.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

Authors:  M P Wautier; O Chappey; S Corda; D M Stern; A M Schmidt; J L Wautier
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

9.  Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.

Authors:  Sun-Mi Won; Youn-Hee Park; Hee-Jung Kim; Kwon-Moo Park; Won-Jung Lee
Journal:  Exp Mol Med       Date:  2006-10-31       Impact factor: 8.718

10.  Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients.

Authors:  Eui-Young Choi; Hyuck Moon Kwon; Chul-Woo Ahn; Geun Taek Lee; Boyoung Joung; Bum Kee Hong; Young Won Yoon; Dongsoo Kim; Ki-Hyun Byun; Tae Soo Kang; Se-Jung Yoon; Sung Woo Kwon; Sung-Ju Lee; Jong-Kwan Park; Hyun-Seung Kim
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more
  14 in total

1.  Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.

Authors:  Song-Tao Tang; Qiu Zhang; Hai-Qin Tang; Chang-Jiang Wang; Huan Su; Qing Zhou; Wei Wei; Hua-Qing Zhu; Yuan Wang
Journal:  Endocrine       Date:  2016-01-12       Impact factor: 3.633

2.  Anthrax lethal toxin suppresses high glucose induced VEGF over secretion through a post-translational mechanism.

Authors:  Wei-Wei Zhang; Xin Wang; Ping Xie; Song-Tao Yuan; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

Review 3.  The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Expert Rev Mol Med       Date:  2009-03-12       Impact factor: 5.600

4.  Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome.

Authors:  Aaron J Trask; Paige S Katz; Amy P Kelly; Maarten L Galantowicz; Mary J Cismowski; T Aaron West; Zachary P Neeb; Zachary C Berwick; Adam G Goodwill; Mouhamad Alloosh; Johnathan D Tune; Michael Sturek; Pamela A Lucchesi
Journal:  J Appl Physiol (1985)       Date:  2012-07-26

Review 5.  Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation.

Authors:  Shi Fang Yan; Shi Du Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

6.  Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.

Authors:  Sho-Ichi Yamagishi; Nobutaka Nakamura; Mika Suematsu; Kuniyoshi Kaseda; Takanori Matsui
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

7.  Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus.

Authors:  Barathi Rajaraman; Nirupama Ramadas; Sundar Krishnasamy; Vidya Ravi; Atima Pathak; C S Devasena; Krishnan Swaminathan; Arunkumar Ganeshprasad; Ashok Ayyappa Kuppuswamy; Srinivasan Vedantham
Journal:  Mol Cell Biochem       Date:  2019-02-14       Impact factor: 3.396

8.  Nonenzymatic glycation interferes with fibronectin-integrin interactions in vascular smooth muscle cells.

Authors:  Srijita Dhar; Zhe Sun; Gerald A Meininger; Michael A Hill
Journal:  Microcirculation       Date:  2017-04       Impact factor: 2.628

9.  ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells.

Authors:  Pengfei Hu; Dongwu Lai; Peilin Lu; Jing Gao; Hong He
Journal:  Int J Mol Med       Date:  2012-01-23       Impact factor: 4.101

Review 10.  Receptor for advanced glycation end products and its involvement in inflammatory diseases.

Authors:  Yaw Kuang Chuah; Rusliza Basir; Herni Talib; Tung Hing Tie; Norshariza Nordin
Journal:  Int J Inflam       Date:  2013-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.